Atxn2 Protein (Ataxin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Atxn2 Protein (Ataxin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ataxin-2 (ATXN2) is a large RNA-binding protein implicated in RNA metabolism, stress granule formation, and translational control. Gain-of-function mutations and intermediate polyglutamine expansions in ATXN2 are associated with multiple neurodegenerative disorders, including [Parkinson's disease](/diseases/parkinsons-disease), ALS, and frontotemporal dementia [1]. [@block]
Overview
ATXN2 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of ATXN2 is associated with neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), Parkinson's disease, and related disorders. [@modulate]
Structure
ATXN2 is a 1,313 amino acid protein with several functional domains: [@enhance]
N-terminal region: Contains the polyglutamine (polyQ) tract
Lsm domain: Like-Sm protein domain for RNA binding
PABP-interacting motif 2 (PAM2): Mediates interaction with poly(A)-binding protein (PABP)
C-terminal region: Associated with stress granule localization
The polyQ tract length determines disease risk: [@sat]
Normal: <22 glutamines
Intermediate: 27-33 glutamines (risk factor for PD)
Pathogenic: >34 glutamines (spinocerebellar ataxia type 2)
Normal Function
RNA Metabolism
ATXN2 participates in various RNA processing functions:
mRNA stability and decay
Translation regulation
miRNA processing
RNA granule transport
Stress Granule Formation
Under cellular stress, ATXN2 localizes to stress granules:
Phase-separated membraneless organelles
Contain untranslated mRNAs and RNA-binding proteins
The study of Atxn2 Protein (Ataxin 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data